Merck (MRK) Change in Inventory (2009)

Merck (MRK) reported Change in Inventory of -$1.1 billion for Q4 2009, down 831.08% quarter-over-quarter from $148.0 million in Q3 2009.

Merck (MRK) Change in Inventory (2009) Analysis & Trends

Merck (MRK) has 1 years of Change in Inventory data on file, last reported at -$1.1 billion in Q4 2009.

Change in Inventory for Q4 2009 came in at -$1.1 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2009 was -$370.0 million (changed N/A YoY), and the FY2025 annual result was $1.2 billion, up 41.32% from the prior year.
Change in Inventory slipped to -$1.1 billion in Q4 2009 per MRK's latest filing, from $148.0 million in the prior quarter.
Over five years, Change in Inventory peaked at $148.0 million in Q3 2009 and troughed at -$1.1 billion in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn	-
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn	-
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn	431.00 Mn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn	184.00 Mn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn	-
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn	-18.00 Mn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn	52.00 Mn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn	-14.00 Mn
10	Novartis Ag	108.28 Bn	107.60 Bn	-	-95.00 Mn

Download Data